How We Measure TPE Results: The Labs Behind Every Session

Most TPE clinics perform the procedure and send you home. At Liondale, every session is bracketed by a pre-treatment baseline draw and a post-treatment follow-up panel. We measure the same core markers before and after: CRP, IL-6, fibrinogen, a metabolic panel, a lipid panel and, where clinically relevant, epigenetic clock biomarkers. The point is simple. You should know whether the intervention moved something, not only whether you felt different the next morning. Dr. Bissoon reviews every result personally before your next session is planned.

If you want the broader overview first, start with therapeutic plasma exchange at Liondale Medical. If cost is your first filter, read our TPE cost in NYC guide. This page is narrower. It is about measurement.

How Quickly Does Plasma Exchange Work? It Depends What You Measure

Patients often ask how soon TPE works, and the answer differs by marker. Some changes are immediate and expected: because plasma is physically removed, plasma proteins such as fibrinogen fall right after a session and then recover. Inflammatory markers like CRP and IL-6 are better judged across a series of sessions than after a single one. Biological age estimates were assessed over a multi-month protocol in the 2025 clinical trial, not after one visit. Subjective changes in energy or clarity, when they happen, can appear within days, but they are not a substitute for data. Measuring at set points turns “how quickly does it work?” into an answer specific to you.

Why Tracking Changes Everything

TPE is not cheap. When a procedure sits in the $10,000-per-session range, the standard cannot be “how did you feel the next day?” That matters, but it is not enough. Tracking turns an expensive intervention into a feedback loop. Without one, you are paying for an experience and hoping it became an outcome.

With labs, the questions get sharper. Did inflammatory burden shift? Did CRP drop or stay flat? Did IL-6 calm down? Did fibrinogen move the way we expected after plasma exchange, and how did it restore? If markers move, how long does the effect hold before the next session? Those answers determine frequency, whether IVIG belongs in the plan, whether another therapy should be layered in and sometimes whether we should stop. Tracking also protects patients from autopilot care. If the numbers are not moving, we change the plan or pause it. Good medicine has an off-ramp. For the wider case for measurement in longevity care, see why precision diagnostics beat standard labs. If you are comparing clinics, ask each what it measures before and after treatment, and see how NYC TPE clinics compare.

What a Typical Lab Sequence Looks Like

The exact schedule is set by your physician and your protocol, but the logic is consistent:

1. Consultation and baseline draw. Your history, medications and goals are reviewed, and baseline labs are drawn before any session is scheduled.

2. Pre-treatment draw at session. The same core markers are checked so each session has its own starting point.

3. Post-treatment draw. The core panel is repeated after the session, using the same markers so comparisons are apples to apples.

4. Physician review. Dr. Bissoon reviews the pattern before the next session is planned, and you see the results with context.

5. Adjustment. Frequency, IVIG decisions or complementary therapies are changed if the data calls for it.

Timing of the post-treatment draw can vary by marker and protocol. What does not vary is the principle: we do not wait months and guess. If you are curious how a sample moves from your arm to your report, see the journey of a blood sample after your draw.

The Pre-Treatment Baseline: What We Draw and Why

The baseline is not paperwork. It shows what inflammatory picture a patient brings into treatment, whether the systems handling fluid and metabolic stress look steady and whether the person is a sensible TPE candidate. It also gives us a fair starting line, without which every “improvement” claim is mushy.

• CRP (C-reactive protein): a broad marker of systemic inflammation. It can rise with acute illness, chronic inflammatory load, metabolic dysfunction and poor recovery, and that breadth is exactly why it is useful at baseline.
• IL-6 (interleukin-6): a pro-inflammatory cytokine that sits upstream of CRP and drives acute-phase responses. When it is elevated, the inflammatory signal may still be actively generated.
• Fibrinogen: an acute-phase protein involved in both inflammation and coagulation, so interpretation needs care.
• Metabolic panel: glucose, liver enzymes such as ALT and AST, kidney markers such as creatinine, BUN and eGFR, and electrolytes. It tells us whether the system looks stable before we run fluid through an extracorporeal circuit.
• Lipid panel: total cholesterol, LDL, HDL and triglycerides, which place inflammatory markers in a broader cardiometabolic frame.
• Epigenetic clock biomarkers, where relevant: DNA methylation-based estimates of biological age, added when tracking biological age is part of why the patient is pursuing TPE.

Depending on your plan, additional labs such as hormones or immunoglobulin levels may also be included. Because plasma exchange removes some useful proteins along with unwanted ones, immunoglobulin monitoring can be relevant for patients repeating sessions. Where environmental exposure is a concern, we discuss what can and cannot be measured in our article on TPE and microplastics.

The baseline also functions as candidacy screening. If the pattern is not what we would expect in a patient likely to benefit, that changes the conversation before any session is booked. Sometimes the issue is untreated metabolic dysfunction or a clearer inflammatory driver. Sometimes the real first move is basic medical housekeeping. For who is and is not a fit, read our TPE safety and candidacy guide. For the broader biomarker approach, see longevity labs and biomarkers and personalized longevity planning with precision diagnostics.

The Post-Treatment Follow-Up Panel

After each session we repeat the same core markers. If you change the labs every time, you lose the thread. What does a useful response look like? CRP trends toward a better range. IL-6 comes down. Fibrinogen drops as expected, then restores in a pattern that makes physiologic sense. The metabolic panel stays stable or improves, which tells us the procedure is being tolerated cleanly. When epigenetic clock biomarkers are part of the plan, we look for movement in the direction the 2025 Aging Cell trial made interesting.

A non-response looks different: one number improves while the rest of the picture does not, a marker dips once and snaps back, or the patient feels terrific for 36 hours while the lab picture is unchanged. A partial signal still matters. It is just not proof that the protocol is dialed in. I would rather see an inconvenient result than a comforting fiction.

What Each Marker Tells Us in a TPE Context

CRP. It is the broad inflammation signal, and that is both its weakness and its strength. It can rise with infection, metabolic strain, poor sleep, autoimmune activity, hard training or dental inflammation, so a CRP result never speaks alone. But it gives a fast read on whether total inflammatory burden looks different after treatment. Normal and optimal are not the same target: a laboratory may call a CRP under 10 mg/L normal, which is not necessarily where I want a high-functioning 55-year-old to live. The question is whether you moved toward a better biologic state, not whether you stayed inside a broad reference range.

IL-6. CRP is often the downstream smoke, and IL-6 can help show where the fire is being driven. If CRP improves but IL-6 stays sticky, I do not declare victory. I ask what is still feeding the signal: infection, autoimmune activity, adipose-driven inflammation or recovery issues. That is where lab interpretation becomes clinical judgment, not spreadsheet work.

Fibrinogen. Plasma exchange physically removes fibrinogen along with many other plasma proteins, so a post-treatment drop is expected. The real question is how it restores, how fast and to what level. If it rebounds quickly to an unfavorable baseline, the inflammatory and coagulation story underneath may still be active.

Metabolic panel. Less glamorous but essential. TPE involves fluid shifts, vascular access and anticoagulation management, so we want to know the kidneys are handling it well, the liver picture is steady and electrolytes are where they should be. It also keeps us honest: TPE can change part of the terrain, but it does not erase poor sleep, insulin resistance, heavy alcohol use or an untreated endocrine issue.

Lipid panel. It frames the cardiometabolic side of the case. Elevated inflammatory markers alongside a lipid pattern pointing toward metabolic strain carry a different implication than isolated inflammation in an otherwise clean picture, and that shapes what we expect TPE to accomplish.

Epigenetic clock biomarkers. They are useful and interesting, and they are not a clinical diagnosis. We use them when relevant to the patient’s goal, particularly when TPE is pursued because of the biological-age literature. An epigenetic clock can move in the right direction and still not answer whether you will sleep better next week. It does not prove lifespan extension. For the evidence breakdown, read our analysis of the 2025 clinical trial.

When Markers Don’t Move: What Happens

This is the section most clinics avoid, which is why it matters. If CRP has not moved after session two, I want to know why in that specific patient. If IL-6 is unchanged or fibrinogen keeps returning to the same place, that is the case, not a footnote.

A weak clinic response is to keep selling sessions and call it a long-term process. A stronger response asks hard questions. Was frequency too low to sustain the effect? Was IVIG timing wrong for the physiology we are seeing? Is there an underlying driver, such as infection, autoimmune activity or metabolic dysfunction, that TPE will not solve alone? Sometimes the answer is that this patient is not the right fit at this stage.

Possible next moves include increasing frequency for a defined interval, reconsidering whether IVIG belongs in the plan, adding a complementary therapy such as NAD+ IV therapy, ozone or hormone work, or pausing to reassess. The answer is never to keep running sessions the numbers do not support. That is inertia with a luxury price tag.

Kevin MacDonald: What “Moving Into the Green” Means

“Watching all my bloodwork numbers move into or towards the green gives me a lot of confidence in what I’m doing with TPE.” That is a comment from Kevin MacDonald, age 63, a Circulate Health patient. It captures what patients should want: not hype or the vague thrill of doing something expensive, but measured movement. “Into the green” should not simply mean inside the lab’s normal range. For a high-functioning 63-year-old, normal and optimal CRP are not the same, which is why our tracking is oriented toward what is better, not merely what escapes the abnormal flag.

To understand why Liondale built the program this way, read why patients choose Liondale for TPE in NYC. The short answer is physician review, concierge follow-through and a stricter standard for what counts as a result.

How to Use Your Results Between Sessions

Lab results are most useful when you look at them as a trend, not as a single snapshot. Keep a simple record of each panel so you can see direction over time, and bring it to every review. Pay attention to how your results line up with how you feel, but do not let either one overrule the other. A good lab number on a poor day is still information, and a great day with a flat lab picture is too. Other factors can move markers independently of TPE, including recent illness, hard training, poor sleep, changes in medication or a change in diet, so tell your physician about anything unusual before a draw. Try to keep your preparation consistent from one draw to the next. Finally, ask what each target means for you personally and what result would change the plan. When you understand the reasoning behind each number, the data stops being a scorecard and becomes a tool for making better decisions with your physician.

Frequently Asked Questions

Which labs are included with my session?

Each session is tied to the same core lab framework: CRP, IL-6, fibrinogen, a metabolic panel and a lipid panel. Where clinically relevant, Dr. Bissoon may also include epigenetic clock biomarkers to track biological age response. Consistency lets us compare like with like from session to session.

How quickly does plasma exchange work?

It depends on the marker. Plasma proteins change immediately after a session, inflammatory markers are judged across a series of sessions, and biological age estimates were assessed over a multi-month protocol in the 2025 trial. Subjective changes can appear within days but are not a substitute for lab data.

When is the post-treatment draw done?

The post-treatment panel is done after each session as part of the follow-up plan. Exact timing can vary by marker and protocol, but we measure the response in a clinically useful window rather than waiting months and guessing.

What if my markers don’t improve after treatment?

Dr. Bissoon reviews the pattern and decides whether the next move is a frequency change, an IVIG adjustment, a complementary treatment or a pause. If the data does not support continuing on the same path, we say so directly.

Do I need to fast before the lab draw?

Sometimes, especially when the lipid panel is central to the interpretation. Not every draw is handled the same way, and you will get specific preparation instructions before your visit so the numbers are clinically usable. Our note on fasting before blood panels explains the general reasoning.

Can I see my lab results directly?

Yes. You should see what was measured and how it changed. We review results with you so the numbers make sense in context and guide what happens next.

Does Liondale track epigenetic age?

Yes, when it is relevant to the clinical goal. Epigenetic age testing is not necessary for every TPE patient, but it can be useful when treatment is tied to biological age tracking. It is one tool, not the whole story.

Why does fibrinogen drop after a session?

Plasma exchange physically removes plasma proteins, including fibrinogen, so a post-treatment drop is expected. What matters is how it restores and to what level.

Are normal lab ranges the same as optimal ranges?

Not always. Reference ranges describe what is common in a population, while longevity medicine often aims at what is better for a particular patient. CRP is a common example.

Are the labs included in the price of TPE?

At Liondale, the pre- and post-treatment panels accompany every session. See our TPE cost guide for what drives pricing.

If you are considering treatment and want to talk through the lab process before booking, you can contact Liondale Medical. Many patients also start with our safety and candidacy guide and the main TPE service page.

Published May 28th, 2026